Stress hyperglycemia ratio

There are 25 papers on stress hyperglycemia ratio in aging research: 23 observational studies in people, 2 reviews. The newest story, Oct 4, 2026: “High hemoglobin glycation index is linked to incident stroke”.

Biomarker

25 papers study it35 findings

3 new papers in 30 daysSee all 25 papers on stress hyperglycemia ratio

“These five associations remained robust after adjustment for medication use and exclusion of early deaths”
Insulin Resistance Surrogate Indices and All‐Cause Mortality Across Cardiovascular‐Kidney‐Metabolic Syndrome Stages: A Population‐Based Cohort StudyThe Kaohsiung journal of medical sciences2026doi:10.1002/kjm2.70324
  • Humans23

Effects

7

Malnutrition

no changein humans1

1 study
  1. Stress hyperglycemia ratio was not clearly linked with malnutrition in humans (fully adjusted analysis).

    “whereas the association with malnutrition was no longer significant”

    Humansfully adjusted analysisn = 1,401

    Association of stress hyperglycemia ratio with malnutrition, sarcopenia, and frailty in older adults: a cross-sectional study

    BMC geriatrics

More on Malnutrition

CERAD subtest

no changein humans1

1 study
  1. Stress hyperglycemia ratio was not clearly linked with CERAD subtest in older patients with diabetes or prediabetes (all p > 0.05).

    “No statistically significant associations were observed between any of the quartile groups and CERAD (all p > 0.05).”

    Humansin older patients with diabetes or prediabetes

    Association between stress hyperglycemia ratio and cognitive function in older patients with diabetes or prediabetes: a cross-sectional study from the NHANES

    Endocrine journal

More on CERAD subtest

Cognitive function

downin humans1

1 study
  1. Stress hyperglycemia ratio is linked with lower cognitive function in older patients with diabetes or prediabetes (β: -0.26, 95% CI: -0.39 to -0.12).

    “compared to the second quartile, the first [β: -0.26; 95% confidence interval (CI): -0.39- -0.12], third (β: -0.13, 95% CI: -0.25- -0.02), and fourth (β: -0.21, 95% CI: -0.36- -0.06) quartiles were all associated with a decrease in Z-score”

    Humansin older patients with diabetes or prediabetes

    Association between stress hyperglycemia ratio and cognitive function in older patients with diabetes or prediabetes: a cross-sectional study from the NHANES

    Endocrine journal

Mortality prediction performance

no changein humans1

1 study
  1. Stress hyperglycemia ratio was not clearly linked with mortality prediction performance in humans (Compared with triglyceride-glucose index in critically ill patients with heart failure).

    “no statistically significant difference was observed in the predictive performance of SHR and TyG index for mortality at any time points (P>0.05).”

    HumansCompared with triglyceride-glucose index in critically ill patients with heart failure30, 90, 180, and 365 daysn = 1,063

    Head-to-head comparison of stress hyperglycemia ratio versus triglyceride-glucose index for predicting mortality in heart failure: a retrospective cohort study

    Frontiers in endocrinology

Gait speed

downin humans1

1 study
  1. Stress hyperglycemia ratio is linked with worse gait speed in humans (frail older adults with HFpEF and MoCA < 26) (0.65 ± 0.20 m/s vs. 0.72 ± 0.20 m/s, p = 0.0004).

    “Patients with SHR > 1 demonstrated significantly reduced physical performance compared with those with SHR ≤ 1 (mean gait speed 0.65 ± 0.20 m/s vs. 0.72 ± 0.20 m/s, p = 0.0004).”

    Humansfrail older adults with HFpEF and MoCA < 26n = 204

    Stress hyperglycemia ratio and physical frailty in HFpEF

    Cardiovascular diabetology

Cardiovascular mortality

no changein humans1

1 study
  1. Stress hyperglycemia ratio was not clearly linked with cardiovascular mortality in humans (NAFLD).

    “No significant association was found with cardiovascular mortality.”

    HumansNAFLDn = 12,604

    U-shaped association of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in patients with NAFLD: results from the NHANES database prospective cohort study

    BMC gastroenterology

Mortality

no changein humans1

1 study
  1. Stress hyperglycemia ratio was not clearly linked with mortality in humans (non-linear P = 0.942).

    “no significant non-linear relationship was observed between SHR and all-cause mortality (non-linear P = 0.942)”

    Humans

    L-shaped relationship between stress hyperglycemia ratio and cardiovascular disease risk in middle-aged and older adults: Insight from the China Health and Retirement Longitudinal Study

    PloS one

Associations

15

Mortality

upin humans7mixedin humans2HR 1.32–1.84

9 studies
  1. Stress hyperglycemia ratio is associated with mortality in humans (Fully adjusted analysis) (HR 1.774).

    “These five associations remained robust after adjustment for medication use and exclusion of early deaths”

    HumansFully adjusted analysisMedian follow-up 9.7 yearsn = 18,513

    Insulin Resistance Surrogate Indices and All‐Cause Mortality Across Cardiovascular‐Kidney‐Metabolic Syndrome Stages: A Population‐Based Cohort Study

    The Kaohsiung journal of medical sciences

  2. Stress hyperglycemia ratio is linked with a higher risk of mortality in humans (STEMI patients harboring common-CHIP undergoing primary percutaneous coronary intervention) (HR 1.84).

    “elevated SHR itself was an independent risk factor for mortality, specifically in patients harboring common-CHIP or TET2 mutations (HR=1.84 and 1.83, respectively).”

    HumansSTEMI patients harboring common-CHIP undergoing primary percutaneous coronary intervention

    Clonal hematopoiesis of indeterminate potential and stress hyperglycemia ratio among patients with STEMI---from a prospective cohort study

    ESC Congress 2026 abstract

  3. Stress hyperglycemia ratio predicts mortality in humans (hip fracture with perioperative atrial fibrillation) (C-index 0.7688).

    “RCS analysis revealed a J‐shaped nonlinear association between SHR and all‐cause mortality”

    Humanship fracture with perioperative atrial fibrillation36 monthsn = 340

    Prognostic Association and Predictive Value of the Stress Hyperglycemia Ratio for All‑Cause Mortality in Elderly Hip Fracture Patients with Perioperative Atrial Fibrillation

    Research SquarePreprint

  4. Stress hyperglycemia ratio is associated with mortality in humans (surgical or trauma ICU patients).

    “linear association with in-hospital mortality.”

    Humanssurgical or trauma ICU patients

    Association between stress hyperglycemia ratio and delirium risk in elderly surgical patients: a retrospective cohort study

    BMC geriatrics

  5. Stress hyperglycemia ratio predicts mortality in humans (hip fractures) (OR=6.944, 95% CI 2.584 to 18.659).

    “Multivariate logistic regression analysis showed that SHR (p<0.001, OR=6.944, 95% CI 2.584 to 18.659) was an independent risk factor for 28-day all-cause mortality.”

    Humanship fractures28 daysn = 443

    Predictive value of stress hyperglycaemia ratio for 28-day all-cause mortality in elderly patients with hip fracture: a retrospective single-centre study in Beijing Jishuitan Hospital, Capital Medical University, Beijing, China

    BMJ open

  6. Stress hyperglycemia ratio is linked with a higher risk of mortality in humans (elderly ICU patients with delirium) (68% increase, 95% CI 1.17-2.41, p = 0.0053).

    “Each standard deviation (SD) rise in SHR within the ranges of 0.85-1.77 for 28 day mortality and 0.89-1.90 for 365 day mortality corresponded to a 68% increase in 28 day mortality risk”

    Humanselderly ICU patients with deliriumn = 1,088

    Assessment of stress hyperglycemia ratio as a prognostic indicator in geriatric intensive care patients experiencing delirium: a retrospective cohort analysis

    European journal of medical research

  7. Stress hyperglycemia ratio is linked with a higher risk of mortality in humans (patients with type 2 diabetes and obesity) (adjusted HR 1.32, P < 0.001).

    “participants in the highest SHR tertile exhibited significantly elevated hazard ratios (HRs) compared to the reference tertile, with adjusted HRs of 1.32 for all-cause mortality”

    Humanspatients with type 2 diabetes and obesity

    Accelerated biological aging mediates the associations of stress hyperglycemia ratio (SHR) with mortality in type 2 diabetes and obesity (diabesity)

    Cardiovascular diabetology

  8. Stress hyperglycemia ratio is associated with mortality in humans (NAFLD) (thresholds at 0.89 for middle-aged and 0.94 for older adults).

    “a U-shaped relationship was observed between SHR and all-cause mortality in adults aged 40-59 years and ≥ 60 years.”

    HumansNAFLDn = 12,604

    U-shaped association of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in patients with NAFLD: results from the NHANES database prospective cohort study

    BMC gastroenterology

  9. Stress hyperglycemia ratio is linked with a higher risk of mortality in subjects without diabetes (OR 4.31, 95% CI 1.25-14.81).

    “At multivariable analysis, the risks of death (OR 4.31, 95% CI 1.25-14.81), of all complications (OR 5.90, 95% CI 2.22-15.71) and of newly developed systemic infections”

    Humansin subjects without diabetesn = 206

    Prognostic Value of Stress Hyperglycemia in Patients Admitted to Medical/Geriatric Departments for Acute Medical Illness

    Diabetes therapy : research, treatment and education of diabetes and related disorders

Cardiometabolic multimorbidity

upin humans2downin humans1HR 1.13

2 studies
  1. Stress hyperglycemia ratio is linked with a higher risk of cardiometabolic multimorbidity in humans (HR 1.13, 95% CI 1.03-1.24).

    “Each 1-SD increase in the baseline stress-hyperglycemia ratio was associated with 13% higher fully adjusted cardiometabolic multimorbidity risk (hazard ratio = 1.13, 95% confidence interval = 1.03-1.24, p = 0.013)”

    Humans9-yearn = 4,019

    Stress-hyperglycemia ratio, its longitudinal trajectories, and stress-metabolism synergy in predicting cardiometabolic multimorbidity: A nationwide prospective cohort study

    The Journal of international medical research

  2. Stress hyperglycemia ratio is associated with cardiometabolic multimorbidity in humans (external validation in CHARLS) (OR = 1.389 [1.026, 1.880]).

    “external validation in the CHARLS cohort confirming a significant positive association (OR = 1.389, [1.026, 1.880].”

    Humansexternal validation in CHARLS

    Unveiling the relationship between stress-hyperglycemia ratio and cardiometabolic multimorbidity risk using interpretable machine learning

    European journal of medical research

  3. Stress hyperglycemia ratio is linked with a lower risk of cardiometabolic multimorbidity in humans (when SHR is below 0.841) (OR = 0.001 [0.000, 0.004]).

    “When SHR is below 0.841, CMM risk decreases as SHR increases (OR = 0.001 [0.000, 0.004])”

    Humanswhen SHR is below 0.841n = 12,279

    Unveiling the relationship between stress-hyperglycemia ratio and cardiometabolic multimorbidity risk using interpretable machine learning

    European journal of medical research

  4. Stress hyperglycemia ratio is linked with a higher risk of cardiometabolic multimorbidity in humans (OR = 22.131 [10.688, 45.823]).

    “For 1-unit rise in SHR, the risk of CMM rose by 21.131 (OR = 22.131 [10.688, 45.823]).”

    Humansn = 12,279

    Unveiling the relationship between stress-hyperglycemia ratio and cardiometabolic multimorbidity risk using interpretable machine learning

    European journal of medical research

More on Cardiometabolic multimorbidity

Delirium

upin humans2OR 2.79–9.13

2 studies
  1. Stress hyperglycemia ratio is linked with a higher risk of delirium in humans (surgical or trauma ICU patients) (adjusted OR = 2.79; 95% CI: 1.79-4.35).

    “Higher SHR was independently associated with greater odds of delirium (Q4 vs. Q1 adjusted OR = 2.79; 95% CI: 1.79-4.35)”

    Humanssurgical or trauma ICU patients

    Association between stress hyperglycemia ratio and delirium risk in elderly surgical patients: a retrospective cohort study

    BMC geriatrics

  2. Stress hyperglycemia ratio is linked with a higher risk of delirium in humans (community-acquired pneumonia) (OR 9.13, 95% CI 4.44-18.96).

    “SHR (OR = 9.13, 95% CI 4.44-18.96), NLR (OR = 1.12 per unit, 95% CI 1.06-1.19) and PCT (OR = 1.14 per ng/mL, 95% CI 1.06-1.21) were independent predictors of delirium.”

    Humanscommunity-acquired pneumonian = 412

    Direct and indirect associations of stress hyperglycemia with delirium in older adults with community-acquired pneumonia: limited mediation by neutrophil-lymphocyte ratio and procalcitonin

    BMC geriatrics

More on Delirium

30-day all-cause mortality

upin humans1HR 1.27–1.88

1 study
  1. Stress hyperglycemia ratio is associated with 30-day all-cause mortality in humans (Atrial fibrillation with prediabetes; fully adjusted model) (HR 1.27, 95% CI 0.78–2.07; P = 0.338).

    “with no significant association observed in the Pre-DM (HR = 1.27, 95% CI 0.78–2.07, P = 0.338)”

    HumansAtrial fibrillation with prediabetes; fully adjusted model30 daysn = 1,156

    Assessment of stress hyperglycemia ratio to predict mortality in patients with atrial fibrillation across different glucose metabolic states: an observational cohort study with machine learning

    Cardiovascular diabetology

  2. Stress hyperglycemia ratio predicts 30-day all-cause mortality in humans (Atrial fibrillation with normal glucose regulation; fully adjusted model) (HR 1.88, 95% CI 1.15–3.07).

    “high SHR remained an independent risk factor solely in the NGR patients (Hazard Ratio [HR] = 1.88, 95% Confidence Interval [CI] 1.15–3.07, P = 0.011)”

    HumansAtrial fibrillation with normal glucose regulation; fully adjusted model30 daysn = 1,388

    Assessment of stress hyperglycemia ratio to predict mortality in patients with atrial fibrillation across different glucose metabolic states: an observational cohort study with machine learning

    Cardiovascular diabetology

Incident cardiometabolic multimorbidity

upin humans1HR 1.09

1 study
  1. Stress hyperglycemia ratio is associated with incident cardiometabolic multimorbidity in humans (HR 1.09 per SD increase, 95% CI 1.01–1.18).

    “each SD increase in baseline SHR, FI, and SHR-FI was associated with HRs of 1.09 (95% CI, 1.01–1.18), 1.36 (1.26–1.48), and 1.35 (1.26–1.45), respectively.”

    HumansBaseline measurement; free of cardiometabolic multimorbidity at baseline; fully adjusted modeln = 6,096

    Stress-hyperglycemia ratio, frailty index, and their product in relation to incident cardiometabolic multimorbidity comprising diabetes, heart disease, and stroke: a longitudinal analysis of CHARLS

    Cardiovascular diabetology

More on Incident cardiometabolic multimorbidity

Frailty

upin humans1OR 1.62

1 study
  1. Stress hyperglycemia ratio is associated with frailty in humans (low SHR, fully adjusted analysis) (OR 1.62 (95% CI 1.05-2.50), p = 0.031).

    “and frailty (OR: 1.62, 95% CI: 1.05-2.50; p = 0.031)”

    Humanslow SHR, fully adjusted analysisn = 1,401

    Association of stress hyperglycemia ratio with malnutrition, sarcopenia, and frailty in older adults: a cross-sectional study

    BMC geriatrics

Probable sarcopenia

upin humans1OR 1.51

1 study
  1. Stress hyperglycemia ratio is associated with probable sarcopenia in humans (low SHR, fully adjusted analysis) (OR 1.51 (95% CI 1.02-2.25), p = 0.040).

    “low SHR remained independently associated with probable sarcopenia (OR: 1.51, 95% CI: 1.02-2.25; p = 0.040)”

    Humanslow SHR, fully adjusted analysisn = 1,401

    Association of stress hyperglycemia ratio with malnutrition, sarcopenia, and frailty in older adults: a cross-sectional study

    BMC geriatrics

More on Probable sarcopenia

180-day mortality

upin humans1HR 1.35

1 study
  1. Stress hyperglycemia ratio is associated with 180-day mortality in humans (Critically ill patients with heart failure; adjusted for confounders) (HR 1.35 at 180 days; 1.26 at 365 days; 1.47 at 90 days; 1.53 at 30 days).

    “SHR was significantly associated with an increased risk of 180-day, 365-day, 90-day, and 30-day mortality”

    HumansCritically ill patients with heart failure; adjusted for confounders180 daysn = 1,063

    Head-to-head comparison of stress hyperglycemia ratio versus triglyceride-glucose index for predicting mortality in heart failure: a retrospective cohort study

    Frontiers in endocrinology

KDMAgeAccel

upin humans1

1 study
  1. Stress hyperglycemia ratio is associated with KDMAgeAccel in humans (patients with type 2 diabetes and obesity) (β = 5.00, P < 0.01).

    “SHR positively correlated with KDMAgeAccel and PhenoAgeAccel (β = 5.00 and 1.15, respectively, both P < 0.01).”

    Humanspatients with type 2 diabetes and obesity

    Accelerated biological aging mediates the associations of stress hyperglycemia ratio (SHR) with mortality in type 2 diabetes and obesity (diabesity)

    Cardiovascular diabetology

More on KDMAgeAccel

Cancer mortality

upin humans1HR 1.61

1 study
  1. Stress hyperglycemia ratio is linked with a higher risk of cancer mortality in humans (patients with type 2 diabetes and obesity) (adjusted HR 1.61, P < 0.001).

    “and 1.61 for cancer mortality (all P < 0.001).”

    Humanspatients with type 2 diabetes and obesity

    Accelerated biological aging mediates the associations of stress hyperglycemia ratio (SHR) with mortality in type 2 diabetes and obesity (diabesity)

    Cardiovascular diabetology

All 15

Latest

Dec 2025: 1Jan 2026: 1Feb 2026: 1Mar 2026: 1Apr 2026: 0May 2026: 0Jun 2026: 1Jul 2026: 2Aug 2026: 1Sep 2026: 1Oct 2026: 5Nov 2026: 115 papers in 12 months

See all 25 papers on stress hyperglycemia ratio